Higher Medicaid Rebates Expected To Boost Private Payer Discounts Too
Executive Summary
The recently signed health care reform law will enable private payers to seek deeper discounts on drugs than they often can now, because the law, in effect, creates a lower "best price" floor for drugs by increasing the base Medicaid drug rebate to 23.1 percent
You may also be interested in...
CMS Finally Gets An Administrator; Berwick In Until Late 2011, At Least
Before he has to face a congressional confirmation process, incoming CMS Administrator Donald Berwick will have a year and a half to demonstrate he is, as the Obama administration says, "supremely and uniquely qualified" to implement major health care reforms while overseeing the day-to-day operations of the Centers for Medicare and Medicaid Services
CMS Finally Gets An Administrator; Berwick In Until Late 2011, At Least
Before he has to face a congressional confirmation process, incoming CMS Administrator Donald Berwick will have a year and a half to demonstrate he is, as the Obama administration says, "supremely and uniquely qualified" to implement major health care reforms while overseeing the day-to-day operations of the Centers for Medicare and Medicaid Services
Strategies To Ease Short-Term Earnings Pain From Health Reform Include Cost-Cutting, Diversification
With market-based fees and increased Medicaid rebates set to start several years before drug manufacturers will see any benefit of an expanded market from health care reform, consultants are suggesting several ways to counter the short-term negative effect on earnings, including continued cost-cutting and diversification